Loading page
Loading page
Loading substance route
Extreme potency necessitates precise dosing; overdose risk is substantial. Naive users should employ significantly reduced initial doses due to respiratory depression hazard.
Primarily hepatic via CYP3A4. Approximately 99% undergoes N-dealkylation to norfentanyl. Minor pathways include amide hydrolysis to despropionylfentanyl and alkyl hydroxylation to hydroxyfentanyl, which is further N-dealkylated to hydroxynorfentanyl. All metabolites are pharmacologically inactive.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Fentanyl is considered extremely addictive with a high potential for abuse. Its rapid onset and short duration of action lead to compulsive redosing, contributing to strong psychological dependence. The intense but brief euphoria creates powerful reinforcing patterns that drive continued use.
Physical dependence develops rapidly with regular use. Withdrawal symptoms are severe and include seizures, sleep disorders, depression, anxiety, and intense cravings. Withdrawal should not be abrupt and requires medical supervision due to severity.
Fentanyl poses an exceptionally high overdose risk due to its extreme potency (30-100 times more potent than morphine). The amount required to cause toxicity is highly unpredictable. In pharmaceutical form, most overdose deaths occur at serum concentrations around 0.025 μg/mL (range 0.005-0.027 μg/mL). In poly-substance use, blood concentrations as low as 0.007 μg/mL have been associated with fatalities. Over 85% of overdoses involve at least one other drug. The LD50 in humans is unknown. Because of the extremely high strength of pure fentanyl powder, it is very difficult to dilute appropriately, and the resulting mixture is often far too strong.
| Species | Route | Value |
|---|---|---|
| rat | IV | 3 mg/kg |
| rat | oral | 18 mg/kg |
| mouse | IV | 6.9 mg/kg |
| mouse | IP | 17.5 mg/kg |
| mouse | oral | 27.8 mg/kg |
| cat | IV | 1 mg/kg |
| dog | IV | 14 mg/kg |
| monkey | IV | 0.03 mg/kg |
The primary acute danger is respiratory depression, which at overdose levels can cause anoxia, respiratory arrest, and death; this risk is substantially heightened in opioid-naive individuals and when combined with other CNS depressants. Wooden chest syndrome, a sudden rigidity of abdominal muscles and diaphragm causing complete respiratory failure, can occur with high doses and is believed to be the main cause of death in fentanyl overdoses.
Acute cardiovascular effects including bradycardia and vasodilation occur during intoxication; these are generally not associated with long-term cardiac damage at appropriate doses and do not significantly affect cardiac contractility at regular doses.
Constipation is one of the few long-term complications associated with appropriate fentanyl use; tolerance to this effect develops particularly slowly compared to other opioid effects.
Hallucinations, delirium (including narcotic delirium), and confusion have been reported as adverse effects. Post-acute withdrawal may include psychosis in extreme cases. These effects are relatively uncommon during typical use and are more associated with high doses, overdose, or withdrawal states.
Seizures are documented as a severe withdrawal symptom following chronic use and abrupt discontinuation, rather than as a direct effect of fentanyl intoxication. Withdrawal should be conducted gradually under medical supervision to minimize seizure risk.
Fentanyl was first synthesized in 1959 by Belgian scientist Paul Janssen at Janssen Pharmaceutica, his relatively newly established pharmaceutical company. The compound was developed through systematic screening of chemical analogues of pethidine (marketed as Demerol) for enhanced opioid activity,…
Classified as a Schedule 8 controlled drug, meaning it is available for legitimate medical use under strict prescription controls. Additionally designated as a border controlled substance under Criminal Code Act 9.1.314, with further restrictions imposed by individual states and territories. Unauthorized possession, production, or supply is prohibited.
Controlled under Schedule I of the Controlled Drugs and Substances Act. Medical use requires prescription. In some jurisdictions such as Ontario, patients prescribed fentanyl patches must return used patches to pharmacies before receiving prescription refills as a diversion prevention measure.
Listed in Tabella I of the official tables of narcotic and psychotropic substances maintained by the Ministry of Health. Possession, purchase, and sale without authorization are illegal.
Controlled as a Schedule II substance under Russian drug control legislation. Medical use permitted under strict controls; unauthorized possession and distribution are prohibited.
Designated as a 'red prescription' substance, the most restricted prescription category in Turkey. Illegal to sell or possess without a valid prescription from an authorized physician.
Controlled under the Controlled Substances Act as a Schedule II opiate. FDA approved for medical use since 1968. Illegal to sell without a DEA license and illegal to possess without a valid prescription. Certain formulations such as Abstral require distributors to implement FDA-approved risk evaluation and mitigation strategy (REMS) programs.
Legal for medical use under the Arzneimittelgesetz (AMG). Unauthorized sale or possession without a prescription is illegal under the Suchtmittelgesetz (SMG, Narcotic Substances Act).
Listed in Anlage III of the Betäubungsmittelgesetz (Narcotics Act), indicating it is a marketable and prescription-capable narcotic. Can only be prescribed using a special narcotic prescription form (Betäubungsmittelrezept).
Classified as a List I substance under the Opium Act. Medical use permitted with prescription, but unauthorized possession, production, and distribution are criminal offenses.
Specifically named in Verzeichnis A (List A) of controlled substances. Medicinal use is permitted with appropriate authorization, but non-medical possession and supply are prohibited.
Controlled under the Misuse of Drugs Act 1971. Medical use permitted with appropriate prescription, but unauthorized possession, production, or supply carries severe criminal penalties.
14 sources cited